TRACON Pharmaceuticals Inc (TCON.OQ)
16 Feb 2018
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
- BRIEF-Ambrx And Tracon Pharma Announce Commercialization Agreement For TRC105 In China
- BRIEF-Tracon Pharmaceuticals announces positive results from phase 1 trial of TRC102, Fludara
- BRIEF-Tracon Pharma reports third quarter financial results
- BRIEF-683 Capital Management reports 5.4 pct passive stake in Tracon Pharmaceuticals
- BRIEF-Tracon Pharmaceuticals announces completion of enrollment in randomized phase 2B traxar study of TRC105 and Inlyta in renal cell carcinoma